Additionally, trichostatin A, another HDAC inhibitor, restored the expression of the differentiation protein transglutaminase 2 (TG2), usually repressed by MYCN in NB cells, resulting in reduced tumor volume in the same mouse model [164]. The gene discussed is HDAC9; the disease is neuroblastoma.